Cardiology
News
Sleep disorders may be undetected precursors for cardiometabolic disease in U.S. Latinos
Clinicians should consider screening their patients at risk for hypertension and diabetes for both sleep-disordered breathing and insomnia.
News
Statins linked to reduced mortality in COVID-19
A pooled analysis of available data suggest moderate- to high-intensity statin therapy may be beneficial in patients with COVID-19, researchers...
Conference Coverage
First randomized trial reassures on ACEIs, ARBs in COVID-19
The BRACE CORONA study found no difference in key outcomes between patients continuing versus stopping their medication.
Conference Coverage
Gut bacteria linked to cardiovascular, other health conditions
“Microbiota and their metabolites ... could serve as potential therapeutic targets for the maintenance of health and prevention and treatment of...
News
Two PR employees at FDA fired after plasma therapy controversy
The warnings by two public relations experts at the FDA against overpromoting convalescent plasma as a treatment for COVID-19 reportedly led to...
Conference Coverage
EMPEROR-Reduced: Empagliflozin’s HFrEF benefit solidifies class effects
Conference Coverage
Early rhythm control in AFib gains new life
EAST-AFNET 4 trial reanimates rhythm-control strategy as superior for 5-year cardiovascular outcomes.
News
Nine antihypertensive drugs associated with reduced risk of depression
Some but not all drugs in three antihypertensive classes are associated with reduced risk of depression.
News
FDA pulls amputation boxed warning off canagliflozin label
New safety information suggests the risk of amputation, while still increased with canagliflozin, is lower than previously described, particularly...
News
First evidence of SARS-CoV-2 in heart cells
SARS-CoV-2 has been found in cardiac tissue of a child with multisystem inflammatory syndrome related to COVID-19, believed to be first evidence...